Catalyst
Slingshot members are tracking this event:
Shire's (SHPG) ONIVYDE Approved by European Commission for Metastatic Adenocarcinoma
Do you think this event is important to the companies below? How will it affect their stock price?
| Related Companies | Importance
|
Impact on Stocks
|
||||
|---|---|---|---|---|---|---|
| SHPG |
|
|
||||
Slingshot Insights Explained
Catalyst Date
Occurred on:
Oct 18, 2016
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Metastatic Adenocarcinoma, Approval, Marketing Application, Onivyde, Phase 3, Napoli-1
